LIP
ANIX icon

Lighthouse Investment Partners’s Anixa Biosciences ANIX Stock Holding History

Lighthouse Investment Partners’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,980
Closed -$53K – 715
2025
Q4 		$53K Buy
+16,980
New +$69.5K ﹤0.01% 851

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Lighthouse Investment Partners's ANIX Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Anixa Biosciences (ANIX) in Q1 2026, closing a stake of 16,980 shares — an estimated $53K sold.

Lighthouse Investment Partners first reported a position in ANIX in Q4 2025 and held it in 1 quarter. The position peaked at $53K in Q4 2025. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Anixa Biosciences position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 16,980 Anixa Biosciences shares in Q1 2026, an estimated $53K.
  • Lighthouse Investment Partners first reported a position in Anixa Biosciences in Q4 2025 and held it in 1 quarter.
  • Lighthouse Investment Partners's Anixa Biosciences position peaked at $53K in Q4 2025.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.